Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Ropinirole in RLS
NCT00225862Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Started Jan 2005; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00225862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225862.